Ototoxicity from Combined Cisplatin and Radiation Treatment: An In Vitro Study

Objective. Combined cisplatin (CDDP) and radiotherapy is increasingly being used to treat advanced head and neck cancers. As both CDDP and radiation can cause hearing loss, it is important to have a better understanding of the cellular and molecular ototoxic mechanisms involved in combined therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Low, Wong-Kein, Kong, Sylvia W. W., Tan, Michelle G. K.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995915/
https://www.ncbi.nlm.nih.gov/pubmed/21151649
http://dx.doi.org/10.1155/2010/523976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995915/
https://www.ncbi.nlm.nih.gov/pubmed/21151649
http://dx.doi.org/10.1155/2010/523976

Ejemplares similares